Advertisement

Index by author

April 01, 2013; Volume 83,Issue 4

  1. Xiang, Z.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

  2. Yan, Dong

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

  3. Yeh, Ming-Hsin

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  4. Yen, Chia-Jui

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  5. Young, Summer

    1. Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
      Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
      Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477

  6. Yu, Meng-Chieh

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  7. Yu, Yung-Luen

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  8. Zhang, Haoming

    1. Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel
      Haoming Zhang, D. Adam Lauver, Benedict R. Lucchesi and Paul F. Hollenberg
      Molecular Pharmacology April 2013, 83 (4) 848-856; DOI: https://doi.org/10.1124/mol.112.084392
« Previous (Pages : 6 7 8 9 10 ... 10)next »
Back to top

In this issue

Advertisement